Journal
NUCLEIC ACIDS RESEARCH
Volume 42, Issue 11, Pages 7473-7485Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gku402
Keywords
-
Categories
Funding
- National Institutes of Health (Nanomedicine Development Center Award) [PN2EY018244]
- National Institutes of Health Award [PN2EY018244]
- NATIONAL CANCER INSTITUTE [R01CA077337] Funding Source: NIH RePORTER
- NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER
Ask authors/readers for more resources
CRISPR/Cas9 systems are a versatile tool for genome editing due to the highly efficient targeting of DNA sequences complementary to their RNA guide strands. However, it has been shown that RNA-guided Cas9 nuclease cleaves genomic DNA sequences containing mismatches to the guide strand. A better understanding of the CRISPR/Cas9 specificity is needed to minimize off-target cleavage in large mammalian genomes. Here we show that genomic sites could be cleaved by CRISPR/Cas9 systems when DNA sequences contain insertions ('DNA bulge') or deletions ('RNA bulge') compared to the RNA guide strand, and Cas9 nickases used for paired nicking can also tolerate bulges in one of the guide strands. Variants of single-guide RNAs (sgRNAs) for four endogenous loci were used as model systems, and their cleavage activities were quantified at different positions with 1- to 5-bp bulges. We further investigated 114 putative genomic off-target loci of 27 different sgRNAs and confirmed 15 off-target sites, each harboring a single-base bulge and one to three mismatches to the guide strand. Our results strongly indicate the need to perform comprehensive off-target analysis related to DNA and sgRNA bulges in addition to base mismatches, and suggest specific guidelines for reducing potential off-target cleavage.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available